Prestige Wealth Management Group LLC Abiomed Inc Transaction History

Prestige Wealth Management Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$224.73 - $338.64 $2,921 - $4,402	13 New	13 $3,000
Q2 2020 Aug 13, 2020	SELL	$141.4 - $257.09 $14,988 - $27,251	-106 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $92,401 - $138,775	-708 Reduced 86.98%	106 $15,000
Q4 2019 Jan 28, 2020	SELL	$159.31 - $223.54 $11,948 - $16,765	-75 Reduced 8.44%	814 $139,000
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $7,035 - $11,169	-40 Reduced 4.31%	889 $158,000
Q2 2019 Aug 16, 2019	SELL	$250.96 - $284.94 $59,728 - $67,815	-238 Reduced 20.39%	929 $242,000
Q1 2019 Aug 16, 2019	BUY	$276.39 - $362.25 $2,211 - $2,898	8 Added 0.69%	1,167 $334,000
Q4 2018 Apr 16, 2019	BUY	$281.08 - $444.25 $325,771 - $514,885	1,159 New	1,159 $377,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.